To: Chancellor Angela Merkel, Federal Republic of Germany, President of the 2015 G7 Prime Minister Shinzō Abe, Japan Prime Minister David Cameron, United Kingdom Prime Minister Stephen Harper, Canada President François Hollande, Republic of France President Barack Obama, United States of America Prime Minister Matteo Renzi, Republic of Italy Cc: G7 Foreign Ministers and G7...
Read moreA ‘pharma by numbers’ video illustrating the key facts & figures that range from innovation in R&D to access to medicines and global health, and from the economic footprint to public private partnerships. This video is based on the IFPMA yearly flagship publication ‘The Pharmaceutical Industry & Global Health – Facts & Figures 2014’
Read moreA conference you should not miss: Caroline Mendy, IFPMA Regulatory Policy Manager, invites those interested in access to medicines and regulatory issues in and for Africa to join the IFPMA and Drug Information Association, in Dakar, 26 — 29 April 2015. Have your say on ‘Moving towards Regulatory Harmonisation to enhance Access to Medicines in...
Read moreWhat can be done to speed up access to new medicines for patients and improve quality, safety, and efficacy of medicines in Asia The 2015 Asia Regulatory Conference (ARC) on February 4-5 in Chinese Taipei brought together over 250 stakeholders from regulatory, pharmaceutical, academic, civil society, international and non-governmental organisations, including policy experts from Asia....
Read moreDr Abraham M. Palache, Influenza Scientist, Consultant at Abbott Biologicals and IFPMA Influenza Vaccine Supply International Task Force, talks about the importance of taking the flu shot. It is all about breaking misconceptions spread by anti-vaxxers. People most at risk should be given priority in receiving the flu shot. Find out who those most at...
Read moreReport shows 13% annual increase of pharmaceutical R&D projects to develop treatments to eliminate and control neglected diseases. In 2014, 186 projects were underway. 38 vaccines and treatments currently undergo clinical trials, 10 of which are in final stages. Projects include potential treatments and vaccines for TB, sleeping sickness, malaria, dengue, Chagas, schistosomiasis, intestinal...
Read more